← Analysis
The Record Decline That Did Not Reach Everyone
US overdose deaths fell 27% in 2024, the steepest one-year drop ever recorded, and life expectancy hit a record high. Both are real. Neither reached every community equally — Black and Native American death rates remain far above the national average, and the life-expectancy gap for both groups is still measured in years, not months.

Drug overdose deaths in the United States fell further and faster in 2024 than in any single year ever recorded. Life expectancy rose to a record high the same year, in part because of that decline. Both are real, verified, historic facts — and neither one landed the same way for every American.

The scale of the national turnaround. US drug overdose deaths fell from an estimated 110,037 in 2023 to 80,391 in 2024 — a drop of roughly 27%, the steepest one-year decline ever recorded, surpassing the previous record set in 2018.[1] Fentanyl-involved deaths fell nearly 37%, from about 76,282 to 48,422. Opioid deaths overall fell from 83,140 to 54,743. Declines occurred in nearly every state, with the steepest single-year drops — 35% or more — in Louisiana, Michigan, New Hampshire, Ohio, Virginia, West Virginia, Wisconsin, and Washington, DC.[1] The CDC’s own January 2026 report ties this directly to a second record: US life expectancy reached its highest point ever recorded in 2024.[2]

It is not close to universal, and the same data that shows the decline shows exactly where it stalled. Non-Hispanic Black Americans had the largest percentage decrease of any group in 2023–2024, a 29.3% drop — and still ended 2024 with an overdose death rate of 36.0 per 100,000, 1.51 times the national average of 23.7.[3] Non-Hispanic American Indian and Alaska Native people had the highest overdose death rate of any group in 2024, at 50.8 per 100,000 — more than double the national average — and a below-average improvement, a 20.1% decline versus the roughly 24–27% national figure.[3] Longer-run data makes the gap plainer still: between 1999 and 2022, overdose mortality rose 249.3% among Black Americans and 166.3% among American Indian and Alaska Native Americans — both far steeper than the national trend the recent decline is now reversing.[4]

The life-expectancy record carries the identical shape. As of 2023, life expectancy stood at 70.1 years for American Indian and Alaska Native people and 74.0 years for Black Americans, against 78.4 years for White Americans and 81.3 for Hispanic Americans.[5] In parts of the western United States, life expectancy among Native Americans has fallen below 64 years.[5] Some of the gaps are narrowing — American Indian and Alaska Native life expectancy rose 4.5 years between 2021 and 2023, more than any other group — but a county-level analysis found Black life expectancy still trailing White life expectancy in 1,287 of 1,480 US counties with reliable data, by as much as 15.5 years in the widest cases.[5]

Both halves are the real finding, held together rather than one canceling the other. The national numbers are not manufactured or exaggerated — more Americans are alive today who would not be under the prior trend, and that is true regardless of which community they belong to. It is equally true that American Indian, Alaska Native, and Black communities are recovering from a steeper fall and are still landing further from the floor than the national average describes. A real improvement and a real, unclosed gap are both accurate descriptions of the same year.

The takeaway Who’s on the lever No single policy produced the national decline, and no single policy explains why it reached some communities faster than others -- naloxone distribution, fentanyl-test-strip access, treatment funding, and law-enforcement supply disruption all moved at once, unevenly, across states and health systems with very different existing infrastructure. The communities with the least improvement are largely the same ones with the least infrastructure to begin with -- Indian Health Service facilities and rural/reservation health systems chronically underfunded relative to need, urban Black communities with documented gaps in treatment-access and naloxone distribution. The record decline is real. It ran through the infrastructure that already existed, and where that infrastructure was thinnest, the record shows it plainly.
Sources
  1. Centers for Disease Control and Prevention, CDC Reports Nearly 24% Decline in U.S. Drug Overdose Deaths
  2. Centers for Disease Control and Prevention, U.S. Life Expectancy Hits Record High as Drug Overdose Deaths Decline in 2024
  3. PMC (National Library of Medicine), Charting the Decline of the Fourth Wave: US Overdose Deaths by Race, Ethnicity, and Substance Involvement
  4. PMC (National Library of Medicine), Widening Racial Disparities in the U.S. Overdose Epidemic
  5. KFF, Racial Disparities in Life Expectancy